Balaji Amines [BALAMINES] vs Grauer & Weil [GRAUWEIL] Detailed Stock Comparison

Balaji Amines
NSE
Loading...

Grauer & Weil
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Balaji Amines wins in 9 metrics, Grauer & Weil wins in 11 metrics, with 0 ties. Grauer & Weil appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Balaji Amines | Grauer & Weil | Better |
---|---|---|---|
P/E Ratio (TTM) | 32.71 | 27.36 | Grauer & Weil |
Price-to-Book Ratio | 2.70 | 4.58 | Balaji Amines |
Debt-to-Equity Ratio | 0.55 | 1.26 | Balaji Amines |
PEG Ratio | -1.42 | 38.13 | Balaji Amines |
EV/EBITDA | 21.89 | 20.09 | Grauer & Weil |
Profit Margin (TTM) | 11.11% | 13.85% | Grauer & Weil |
Operating Margin (TTM) | 11.36% | 7.46% | Balaji Amines |
EBITDA Margin (TTM) | 11.36% | 7.46% | Balaji Amines |
Return on Equity | 7.80% | 18.02% | Grauer & Weil |
Return on Assets (TTM) | 6.99% | 8.70% | Grauer & Weil |
Free Cash Flow (TTM) | $685.60M | $999.80M | Grauer & Weil |
Dividend Yield | 0.65% | 1.05% | Grauer & Weil |
1-Year Return | -30.81% | 9.60% | Grauer & Weil |
Price-to-Sales Ratio (TTM) | 3.63 | 3.79 | Balaji Amines |
Enterprise Value | $48.61B | $37.72B | Balaji Amines |
EV/Revenue Ratio | 3.55 | 3.32 | Grauer & Weil |
Gross Profit Margin (TTM) | 40.84% | 41.05% | Grauer & Weil |
Revenue per Share (TTM) | $423 | $25 | Balaji Amines |
Earnings per Share (Diluted) | $47.01 | $3.47 | Balaji Amines |
Beta (Stock Volatility) | 0.61 | 0.28 | Grauer & Weil |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Balaji Amines vs Grauer & Weil Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Balaji Amines | -0.78% | -10.07% | -20.03% | 22.44% | -8.44% | -15.64% |
Grauer & Weil | 1.47% | -0.52% | -8.37% | 18.19% | 0.93% | -8.46% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Balaji Amines | -30.81% | -56.73% | 114.42% | 988.95% | 3,861.87% | 5,310.27% |
Grauer & Weil | 9.60% | 47.21% | 147.69% | 405.77% | 1,019.05% | 755.68% |
Performance & Financial Health Analysis: Balaji Amines vs Grauer & Weil
Metric | BALAMINES | GRAUWEIL |
---|---|---|
Market Information | ||
Market Cap | ₹49.82B | ₹43.05B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 86,648 | 146,830 |
90 Day Avg. Volume | 128,730 | 195,422 |
Last Close | ₹1,521.10 | ₹96.35 |
52 Week Range | ₹1,127.55 - ₹2,433.00 | ₹78.00 - ₹120.00 |
% from 52W High | -37.48% | -19.71% |
All-Time High | ₹5,223.55 (Sep 13, 2021) | ₹204.80 (Feb 26, 2024) |
% from All-Time High | -70.88% | -52.95% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.07% | 0.02% |
Quarterly Earnings Growth | -0.12% | -0.12% |
Financial Health | ||
Profit Margin (TTM) | 0.11% | 0.14% |
Operating Margin (TTM) | 0.11% | 0.07% |
Return on Equity (TTM) | 0.08% | 0.18% |
Debt to Equity (MRQ) | 0.55 | 1.26 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹569.45 | ₹20.72 |
Cash per Share (MRQ) | ₹108.10 | ₹11.87 |
Operating Cash Flow (TTM) | ₹2.65B | ₹1.44B |
Levered Free Cash Flow (TTM) | ₹1.58B | ₹927.08M |
Dividends | ||
Last 12-Month Dividend Yield | 0.65% | 1.05% |
Last 12-Month Dividend | ₹11.00 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Balaji Amines vs Grauer & Weil
Metric | BALAMINES | GRAUWEIL |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 32.71 | 27.36 |
Forward P/E | 20.22 | 38.13 |
PEG Ratio | -1.42 | 38.13 |
Price to Sales (TTM) | 3.63 | 3.79 |
Price to Book (MRQ) | 2.70 | 4.58 |
Market Capitalization | ||
Market Capitalization | ₹49.82B | ₹43.05B |
Enterprise Value | ₹48.61B | ₹37.72B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 3.55 | 3.32 |
Enterprise to EBITDA | 21.89 | 20.09 |
Risk & Other Metrics | ||
Beta | 0.61 | 0.28 |
Book Value per Share (MRQ) | ₹569.45 | ₹20.72 |
Financial Statements Comparison: Balaji Amines vs Grauer & Weil
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | BALAMINES | GRAUWEIL |
---|---|---|
Revenue/Sales | ₹3.58B | ₹3.40B |
Cost of Goods Sold | ₹2.12B | ₹2.00B |
Gross Profit | ₹1.46B | ₹1.40B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹407.22M | ₹237.20M |
EBITDA | ₹637.15M | ₹417.40M |
Pre-Tax Income | ₹490.13M | ₹343.50M |
Income Tax | ₹124.86M | ₹86.10M |
Net Income (Profit) | ₹365.27M | ₹257.40M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | BALAMINES | GRAUWEIL |
---|---|---|
Cash & Equivalents | ₹1.49B | ₹1.08B |
Total Current Assets | ₹9.41B | ₹9.36B |
Total Current Liabilities | ₹1.30B | ₹2.97B |
Long-Term Debt | ₹18.83M | ₹37.30M |
Total Shareholders Equity | ₹20.18B | ₹9.39B |
Retained Earnings | ₹16.46B | N/A |
Property, Plant & Equipment | ₹4.14M | ₹2.47B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | BALAMINES | GRAUWEIL |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | BALAMINES | GRAUWEIL |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 86,648 | 146,830 |
Average Daily Volume (90 Day) | 128,730 | 195,422 |
Shares Outstanding | 32.40M | 453.41M |
Float Shares | 9.83M | 127.47M |
% Held by Insiders | 0.68% | 0.72% |
% Held by Institutions | 0.03% | 0.00% |
Dividend Analysis & Yield Comparison: Balaji Amines vs Grauer & Weil
Metric | BALAMINES | GRAUWEIL |
---|---|---|
Last 12-Month Dividend | ₹11.00 | ₹1.00 |
Last 12-Month Dividend Yield | 0.65% | 1.05% |
3-Year Avg Annual Dividend | ₹10.67 | ₹0.58 |
3-Year Avg Dividend Yield | 0.51% | 0.45% |
3-Year Total Dividends | ₹32.00 | ₹1.73 |
Ex-Dividend Date | Aug 01, 2025 | Aug 06, 2025 |